U.S. UNFRACTIONATED HEPARIN MARKET ANALYSIS

U.S. Unfractionated Heparin Market, by Source (Porcine and Bovine), by Injection Type (IV Injection and Subcutaneous Injection), and by Disease Indication (Venous Thromboembolism, Cardioversion of Atrial Fibrillation, and Pulmonary Embolism & Arterial Embolism) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Published In : Dec 2019
Code : CMI3187
Pages :82
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

Increasing number of people suffering from venous thromboembolism (VTE) is subsequently resulting in rising demand for heparin. For instance, according to the American Heart Association Inc. (AHA), the study published in Burden of Thrombosis in 2016 reports that majority of the data on the incidence and mortality of venous thromboembolism (VTE) comes from high-income countries, especially North America.